PENTAX Medical (a division of HOYA Group) and Jiangsu Vedkang Medical Science and Technology Co., Ltd (Vedkang) today announced the establishment of a joint venture- PENTAX Medical Therapeutics (Jiangsu) Co., Ltd.(*) to develop single-use therapeutics products in the field of flexible medical endoscopy. The new company will offer innovative single-use devices to global customers through the PENTAX Medical sales network strengthened by Vedkang’s exceptionally reliable and quality-focused production and R & D infrastructure.
Medical flexible endoscopes and therapeutic devices are used in minimally invasive procedures to benefit patients, physicians, and health care systems with significant reductions in procedure cost/complexity resulting in dramatic improvements in patient recovery time.
“We are excited to establish this collaboration with Vedkang to further advance our mission to improve the standard of patient care and quality of healthcare around the world. Our collaboration will support the fast-growing Endotherapy segment as new and innovative procedures achieve traction and penetration worldwide. Instilling clinical confidence by delivering high performance, reliability and value to our customers is at the core of everything we do,” said Gerald W. Bottero, Global President of PENTAX Medical. “Now PENTAX Medical together with Vedkang looks forward to offering integrated endoscopy solutions to our valued global customers.”
The new company, PENTAX Medical Therapeutics (Jiangsu) Co., Ltd. (*) will be headquartered in China and plans to develop and commercialize products for key markets in Europe, Asia and Americas.
“PENTAX Medical has always been a valuable business partner to Vedkang, and we are delighted to continue our close relationship in this joint venture by pursuing further possibilities with doctors and patients across the world.”, said Mr. Zhuang XiaoJing, The Chairman and CEO of Vedkang.
(*)The joint-venture company’s name is subjective to final government approval